Recognising the Gaps: Risk, LDL-C Targets, and Missed Action in ASCVD Care

This CME-accredited session explores how cardiovascular risk assessment and LDL-C targets can be translated into more effective management of patients with atherosclerotic cardiovascular disease (ASCVD). The session highlights the importance of recognizing high- and very-high-risk patients, defining appropriate risk-based LDL-C targets, and interpreting LDL-C results within the individual patient context. This interactive course also addresses common gaps between LDL-C measurement and clinical action, with practical guidance on moving from passive monitoring to decision-relevant follow-up. Participants will gain a structured approach to linking risk classification, LDL-C targets, treatment assessment, and subsequent management decisions in routine clinical practice.